A consolidação do marco regulatório das parcerias para o desenvolvimento produtivo

Um dos instrumentos da atual política industrial brasileira são as Parcerias para o Desenvolvimento Produtivo (PDP). Em agosto de 2014, o novo marco regulatório das PDP foi colocado em consulta pública, dando origem à Portaria nº 2.531, de 12 de novembro de 2014, a qual redefine as diretrizes e os critérios para a definição da lista de produtos estratégicos para o SUS e o estabelecimento das PDP e disciplina os respectivos processos de submissão,instrução, decisão, transferência e absorção de tecnologia, aquisição de produtos estratégicos para o SUS no âmbito das PDP, monitoramento e avaliação. A elaboração deste artigo teve como objetivo verificar a consolidação das PDP e de seu novo marco regulatório como ferramenta para fomento, incentivo e desenvolvimento do CEIS, através da pesquisa documental e análise de conteúdo da Portaria GM/MS nº 2.531/2014. Verificou-se que essa portaria consolidou todo o rito processual em um único documento a ser adotado pelo governo federal na gestão das PDP, tornando esta uma política de Estado com um marco institucional seguro e estável; e fortalecendo a saúde como parte da agenda da política nacional de desenvolvimento, com um processo deliberativo interministerial

The Challenge of Administrative Sanctions Against Suppliers in Public Administration

Sanctions are imposed against countries or organizations when they fail to comply with a set of legal rules. This article focuses on the process of implementing a supplier sanction model at the Federal University of Minas Gerais, Brazil. It identifies the contributions and limits of the administrative sanctions model in public procurement. The article follows a qualitative research approach and triangulates data sources obtained from semistructured interviews, a document analysis of university purchasing records, and field diaries. It was found that there is an increase in efficiency in the delivery time of purchased items. However, the research found that there is a need for certain improvements, such as the disclosure of the services offered, an expansion of the scope of action, and user empowerment to extract all the potential benefits that the implemented structure offers. The article concludes that this supplier sanction model contributes to the improvement of administrative sanctions management and serves as a reference model for public services. It also assists public managers at the federal university to comply with the law while gaining efficiency

A CONSOLIDAÇÃO DO MARCO REGULATÓRIO DAS PARCERIAS PARA O DESENVOLVIMENTO PRODUTIVO

Um dos instrumentos da atual política industrial brasileira são as Parcerias para o Desenvolvimento Produtivo (PDP). Em agosto de 2014, o novo marco regulatório das PDP foi colocado em consulta pública, dando origem à Portaria nº 2.531, de 12 de novembro de 2014, a qual redefine as diretrizes e os critérios para a definição da lista de produtos estratégicos para o SUS e o estabelecimento das PDP e disciplina os respectivos processos de submissão,instrução, decisão, transferência e absorção de tecnologia, aquisição de produtos estratégicos para o SUS no âmbito das PDP, monitoramento e avaliação. A elaboração deste artigo teve como objetivo verificar a consolidação das PDP e de seu novo marco regulatório como ferramenta para fomento, incentivo e desenvolvimento do CEIS, através da pesquisa documental e análise de conteúdo da Portaria GM/MS nº 2.531/2014. Verificou-se que essa portaria consolidou todo o rito processual em um único documento a ser adotado pelo governo federal na gestão das PDP, tornando esta uma política de Estado com um marco institucional seguro e estável; e fortalecendo a saúde como parte da agenda da política nacional de desenvolvimento, com um processo deliberativo interministerial.</p

A consolidação do marco regulatório das parcerias para o desenvolvimento produtivo

Um dos instrumentos da atual política industrial brasileira são as Parcerias para o Desenvolvimento Produtivo (PDP). Em agosto de 2014, o novo marco regulatório das PDP foi colocado em consulta pública, dando origem à Portaria nº 2.531, de 12 de novembro de 2014, a qual redefine as diretrizes e os critérios para a definição da lista de produtos estratégicos para o SUS e o estabelecimento das PDP e disciplina os respectivos processos de submissão,instrução, decisão, transferência e absorção de tecnologia, aquisição de produtos estratégicos para o SUS no âmbito das PDP, monitoramento e avaliação. A elaboração deste artigo teve como objetivo verificar a consolidação das PDP e de seu novo marco regulatório como ferramenta para fomento, incentivo e desenvolvimento do CEIS, através da pesquisa documental e análise de conteúdo da Portaria GM/MS nº 2.531/2014. Verificou-se que essa portaria consolidou todo o rito processual em um único documento a ser adotado pelo governo federal na gestão das PDP, tornando esta uma política de Estado com um marco institucional seguro e estável; e fortalecendo a saúde como parte da agenda da política nacional de desenvolvimento, com um processo deliberativo interministerial

Species-specific escape of Plasmodium sporozoites from oocysts of avian, rodent, and human malarial parasites

Submitted by Nuzia Santos ([email protected]) on 2017-07-06T19:18:00Z No. of bitstreams: 1 Orfano_ Alessandra_Species-specific_IRR_2016.pdf: 7110861 bytes, checksum: d66d546952a582fae9e6b5fc6be65c1c (MD5)Approved for entry into archive by Nuzia Santos ([email protected]) on 2017-07-06T19:27:18Z (GMT) No. of bitstreams: 1 Orfano_ Alessandra_Species-specific_IRR_2016.pdf: 7110861 bytes, checksum: d66d546952a582fae9e6b5fc6be65c1c (MD5)Made available in DSpace on 2017-07-06T19:27:18Z (GMT). No. of bitstreams: 1 Orfano_ Alessandra_Species-specific_IRR_2016.pdf: 7110861 bytes, checksum: d66d546952a582fae9e6b5fc6be65c1c (MD5) Previous issue date: 2016Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrazilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil/Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil.Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil/Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Iowa State University. Department of Entomology. Ames, IA, USA/ Johns Hopkins Bloomberg School of Public Health. Department of Molecular Microbiology and Immunology. Baltimore, MD, USA.National Institutes of Health. Laboratory of Malaria and Vector Research. Rockville, MD, USA.Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil.Johns Hopkins Bloomberg School of Public Health. Department of Molecular Microbiology and Immunology. Baltimore, MD, USA.National Institutes of Health. Laboratory of Malaria and Vector Research. Rockville, MD, USA.Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brazil/Fundação de Medicina Tropical Dr Heitor Vieira Dourado. Manaus, AM, Brazil.Background: Malaria is transmitted when an infected mosquito delivers Plasmodium sporozoites into a vertebrate host. There are many species of Plasmodium and, in general, the infection is host-specific. For example, Plasmodium gallinaceum is an avian parasite, while Plasmodium berghei infects mice. These two parasites have been extensively used as experimental models of malaria transmission. Plasmodium falciparum and Plasmodium vivax are the most important agents of human malaria, a life-threatening disease of global importance. To complete their life cycle, Plasmodium parasites must traverse the mosquito midgut and form an oocyst that will divide continuously. Mature oocysts release thousands of sporozoites into the mosquito haemolymph that must reach the salivary gland to infect a new vertebrate host. The current understanding of the biology of oocyst formation and sporozoite release is mostly based on experimental infections with P. berghei, and the conclusions are generalized to other Plasmodium species that infect humans without further morphological analyses. Results: Here, it is described the microanatomy of sporozoite escape from oocysts of four Plasmodium species: the two laboratory models, P. gallinaceum and P. berghei, and the two main species that cause malaria in humans, P. vivax and P. falciparum. It was found that sporozoites have species-specific mechanisms of escape from the oocyst. The two model species of Plasmodium had a common mechanism, in which the oocyst wall breaks down before sporozoites emerge. In contrast, P. vivax and P. falciparum sporozoites show a dynamic escape mechanism from the oocyst via polarized propulsion. Conclusions: This study demonstrated that Plasmodium species do not share a common mechanism of sporozoite escape, as previously thought, but show complex and species-specific mechanisms. In addition, the knowledge of this phenomenon in human Plasmodium can facilitate transmission-blocking studies and not those ones only based on the murine and avian models

Species-specific escape of Plasmodium sporozoites from oocysts of avian, rodent, and human malarial parasites

Background Malaria is transmitted when an infected mosquito delivers Plasmodium sporozoites into a vertebrate host. There are many species of Plasmodium and, in general, the infection is host-specific. For example, Plasmodium gallinaceum is an avian parasite, while Plasmodium berghei infects mice. These two parasites have been extensively used as experimental models of malaria transmission. Plasmodium falciparum and Plasmodium vivax are the most important agents of human malaria, a life-threatening disease of global importance. To complete their life cycle, Plasmodium parasites must traverse the mosquito midgut and form an oocyst that will divide continuously. Mature oocysts release thousands of sporozoites into the mosquito haemolymph that must reach the salivary gland to infect a new vertebrate host. The current understanding of the biology of oocyst formation and sporozoite release is mostly based on experimental infections with P. berghei, and the conclusions are generalized to other Plasmodium species that infect humans without further morphological analyses. Results Here, it is described the microanatomy of sporozoite escape from oocysts of four Plasmodium species: the two laboratory models, P. gallinaceum and P. berghei, and the two main species that cause malaria in humans, P. vivax and P. falciparum. It was found that sporozoites have species-specific mechanisms of escape from the oocyst. The two model species of Plasmodium had a common mechanism, in which the oocyst wall breaks down before sporozoites emerge. In contrast, P. vivax and P. falciparum sporozoites show a dynamic escape mechanism from the oocyst via polarized propulsion. Conclusions This study demonstrated that Plasmodium species do not share a common mechanism of sporozoite escape, as previously thought, but show complex and species-specific mechanisms. In addition, the knowledge of this phenomenon in human Plasmodium can facilitate transmission-blocking studies and not those ones only based on the murine and avian models.Published as Orfano, Alessandra S., Rafael Nacif-Pimenta, Ana PM Duarte, Luis M. Villegas, Nilton B. Rodrigues, Luciana C. Pinto, Keillen MM Campos et al. "Species-specific escape of Plasmodium sporozoites from oocysts of avian, rodent, and human malarial parasites." Malaria journal 15, no. 1 (2016): 394. doi: 10.1186/s12936-016-1451-y</p

Protein malnutrition during gestation and early life decreases neuronal size in the medial prefrontal cortex of post-pubertal rats

Retrospective studies in human populations indicate that protein deprivation during pregnancy and early life (early protein malnutrition, EPM) is associated with cognitive impairments, learning disabilities and may represent a risk factor for the late onset of some psychiatric disorders, fundamentally schizophrenia, a condition where the prefrontal cortex plays an important role. The purpose of this study was to analyze whether EPM affects structural aspects of the rat medial prefrontal cortex (mPFC), such as cortical volume, neuronal density and neuronal soma size, which seem altered in patients with schizophrenia. For this, a rat model of EPM (5% casein from conception to postnatal day 60) was adopted and the rat mPFC volume, total number of neurons and average neuronal volume were evaluated on postnatal day 60 (post-pubertal animals) by histo- and immunohistochemical techniques using unbiased stereological analysis. EPM did not alter the number of NeuN+ neurons in the rat mPFC. However, a very significant decrease in mPFC volume and average neuronal size was observed in malnourished rats. Although the present study does not establish causal relationships between malnutrition and schizophrenia, our results may indicate a similar structural phenomenon in these two situations

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation

Infections caused by SARS-CoV-2 induce a severe acute respiratory syndrome called COVID-19 and have led to more than six million deaths worldwide. Vaccination is the most effective preventative measure, and cellular and humoral immunity is crucial to developing individual protection. Here, we aim to investigate hybrid immunity against SARS-CoV-2 triggered by the ChAadOx1 nCoV-19 vaccine in a Brazilian cohort. We investigated the immune response from ChAadOx1 nCoV-19 vaccination in na&iuml;ve (noCOVID-19) and previously infected individuals (COVID-19) by analyzing levels of D-dimers, total IgG, neutralizing antibodies (Nabs), IFN-&gamma; (interferon-&gamma;) secretion, and immunophenotyping of memory lymphocytes. No significant differences in D-dimer levels were observed 7 or 15 days after vaccination (DAV). All vaccinated individuals presented higher levels of total IgG or Nabs with a positive correlation (R = 0.88). Individuals in the COVID-19 group showed higher levels of antibody and memory B cells, with a faster antibody response starting at 7 DAV compared to noCOVID-19 at 15 DAV. Further, ChAadOx1 nCoV-19 vaccination led to enhanced IFN-&gamma; production (15 DAV) and an increase in activated T CD4+ na&iuml;ve cells in noCOVID-19 individuals in contrast with COVID-19 individuals. Hence, our data support that hybrid immunity triggered by ChAadOx1 nCoV-19 vaccination is associated with enhanced humoral response, together with a balanced cellular response